2021
DOI: 10.21203/rs.3.rs-905421/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Radiomics for Precision Medicine in Glioblastoma

Abstract: Introduction: Being the most common primary brain tumor, glioblastoma presents as an extremely challenging malignancy to treat with dismal outcomes despite treatment. Varying molecular epidemiology of glioblastoma between patients and intra-tumoral heterogeneity explains the failure of current one-size-fits-all treatment modalities. Radiomics uses machine-learning to identify salient features of the tumor on brain imaging and promises patient specific management in glioblastoma patients. Methods: We performed … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 33 publications
0
3
0
Order By: Relevance
“…Classifiers based on various combinations of MRI sequences, genetic information, and clinical data can predict tumor diagnosis, overall survival, and treatment response with reasonable accuracy and non-invasively. Radiomics has the potential to transform the scope of glioma management through personalized medicine, but the application in glioma is still in its infancy and has not yet been translated into clinical decision making (61). Larger sample sizes, standardized image acquisition and data extraction techniques will be needed in the future to develop machine learning models that can be effectively translated into clinical practice.…”
Section: Radiomics Applied To Individualized Treatment Of Gliomamentioning
confidence: 99%
“…Classifiers based on various combinations of MRI sequences, genetic information, and clinical data can predict tumor diagnosis, overall survival, and treatment response with reasonable accuracy and non-invasively. Radiomics has the potential to transform the scope of glioma management through personalized medicine, but the application in glioma is still in its infancy and has not yet been translated into clinical decision making (61). Larger sample sizes, standardized image acquisition and data extraction techniques will be needed in the future to develop machine learning models that can be effectively translated into clinical practice.…”
Section: Radiomics Applied To Individualized Treatment Of Gliomamentioning
confidence: 99%
“…These methods enable extraction and quantification of imaging characteristics in radiological imaging, specifically pattern or texture analysis, which computationally allocates imaging signatures to pathological imaging changes 214,215 . Combined radiomics features (RF) can be used to predict disease status and changes during specific therapy regimens, on the basis of machine learning approaches in high-throughput agnostic analyses (Figure 6) 216 . Because RF based imaging is increasingly commonly used and, access to computational equipment and powerful computational hardware is increasing, RF based image interpretation is expected to be applied in clinical diagnostics in the coming years 217 .…”
Section: Medical Image Computing In Translational Cancer Researchmentioning
confidence: 99%
“…Previously, it has been shown that both radiomic and pathomic image-based signatures can independently predict outcomes of interest in GBM (5,6,21). Moreover, some studies on GBM and other cancer types support the hypothesis that combining radiomic and pathomic features will even further improve prognostication and enhance the understanding of the disease by means of predictive models (28)(29)(30)(31).…”
Section: Introductionmentioning
confidence: 96%